• 1
    Preston-Thomas A, Cass A, O'Rourke P. Trends in the incidence of treated end-stage kidney disease among Indigenous Australians and access to treatment. Aust N Z J Public Health. 2007;31(5):41921.
  • 2
    McDonald S, Chang S, Excell L, editors. ANZDATA Registry Report 2007. Adelaide ( AUST ) : Australia and New Zealand Dialysis and Transplant Registry; 2007.
  • 3
    Cass A, Cunningham J, Snelling P, Wang Z, Hoy W. Exploring the pathways leading from disadvantage to end-stage renal disease for Indigenous Australians (review). Soc Sci Med. 2004;58(4):76785.
  • 4
    Read P. Charles Perkins: A Biography. Revised ed. Melbourne ( AUST ) : Penguin; 2001.
  • 5
    Kirubakaran MG, Pugsley DJ. Morbidity and mortality among Australian aboriginal renal transplant recipients. Transplant Proc. 1992;24(5):1808.
  • 6
    Van Buynder PG, Gaggin JA, Martin D, Pugsley D, Mathews JD. Streptococcal infection and renal disease markers in Australian aboriginal children. Med J Aust. 1992;156(8):53740.
  • 7
    Van Buynder PG, Gaggin JA, Mathews JD. Renal disease patterns in aboriginal Australians. A family-based study in a high incidence community. Med J Aust. 1993;159(2):827. Erratum in: Med J Aust. 1993;159(6):432.
  • 8
    Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Hayhurst BG, Rees M, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int. 1998;54(4):1296304.
  • 9
    Goodfellow AM, Hoy WE, Sriprakash KS, Daly MJ, Reeve MP, Mathews JD. Proteinuria is associated with persistence of antibody to streptococcal M protein in Aboriginal Australians. Epidemiol Infect. 1999;122(1):6775.
  • 10
    Hoy WE, Rees M, Kile E, Mathews JD, McCredie DA, Pugsley DJ, et al. Low birthweight and renal disease in Australian aborigines. Lancet. 1998;352(9143):18267.
  • 11
    Hoy WE, Wang Z, VanBuynder P, Baker PR, McDonald SM, Mathews JD. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int. 2001;60(1):24956.
  • 12
    D'Espaignet ET, Van Ommeren M, Taylor F, Briscoe N, Pentony P. Trends in Australian Mortality, 1921-1988. Canberra ( AUST ) : AGPS; 1991. AIH Mortality Series No.: 1.
  • 13
    Denny, Floyd W Jr. History of Hemolytic Streptococci and Associated Diseases. In: StevensDL, KaplanEL, editors. Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. New York ( NY ) : Oxford University Press; 2000. p. 118.
  • 14
    Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases (review). Lancet Infect Dis. 2005;5(11):68594.
  • 15
    Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D'Agati VD. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore). 2008;87(1):2132.
  • 16
    O'Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW. Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology. Cell Immunol. Epub 2008 Mar 4.
  • 17
    Cameron NE, Cotter MA. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway (review). Curr Drug Targets. 2008;9(1):607.
  • 18
    O'Dea K. Westernisation, insulin resistance and diabetes in Australian aborigines (review). Med J Aust. 1991;155(4):25864.
  • 19
    Munoz E, Powers JR, Nienhuys TG, Mathews JD. Social and environmental factors in 10 aboriginal communities in the Northern Territory: relationship to hospital admissions of children. Med J Aust. 1992;156(8):52933.
  • 20
    Mathews JD. The Menzies School of Health Research offers a new paradigm of cooperative research. Med J Aust. 1998;169(11-12):6259.
  • 21
    Jose DG, Shelton M, Tauro GP, Belbin R, Hosking CS. Deficiency of immunological and phagocytic function in aboriginal children with protein-calorie malnutrition. Med J Aust. 1975;2(18):699705.
  • 22
    Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, et al. Restricted polymorphism of the mannose-binding lectin gene of Indigenous Australians. Hum Mol Genet. 2000;9(10):14816.
  • 23
    Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int. 2006;70(1):10410.
  • 24
    Reynolds K, Gu D, Chen J, Tang X, Yau CL, Yu L, et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73(7):8706.
  • 25
    Hoy WE, Kondalsamy-Chennakesavan SN, Nicol JL. Clinical outcomes associated with changes in a chronic disease treatment program in an Australian Aboriginal community. Med J Aust. 2005;183(6):3059.
  • 26
    Strippoli GF, Craig M, Craig JC. Antihypertensive agents for preventing diabetic kidney disease (Cochrane Review). In: The Cochrane Database of Systematic Reviews, Issue 4 , 2005. Oxford ( UK ) : Update Software; 2005.
  • 27
    Baker PR, Hoy WE, Thomas RE. Cost-effectiveness analysis of a kidney and cardiovascular disease treatment program in an Australian Aboriginal population. Adv Chronic Kidney Dis. 2005;12(1):2231.
  • 28
    Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int Suppl. 2003;(83):6673.
  • 29
    Hughes H. Indigenous Education in the Northern Territory. Sydney ( AUST ) : Centre for Independent Studies; 2008. CIS Policy Monographs No.: 83.
  • 30
    Bailie RS, Wayte KJ. Housing and health in Indigenous communities: key issues for housing and health improvement in remote Aboriginal and Torres Strait Islander communities (review). Aust J Rural Health. 2006;14(5):17883.
  • 31
    Bailie RS, Si D, O'Donoghue L, Dowden M. Indigenous health: effective and sustainable health services through continuous quality improvement. Med J Aust. 2007;186(10):5257.